Table 3 Details of the selected case reports
First author and year of publication | Cecka 2011 | Min Wang 2020 | Suzuki 2011 | Wollina 2015 | Kane 2019 | Nakamura 2012 | Yin 2018 | Zhang 2021 |
|---|---|---|---|---|---|---|---|---|
Risk of recurrence (low, intermediate, high) | High risk | High risk | High risk | Intermediate risk | Intermediate risk | Intermediate risk | High risk | High risk |
Adjuvant imatinib | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Patients with biopsy | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Complications of biopsy | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 |
Number of correct diagnoses from pretreatment biopsies | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Recurrence related to biopsy | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total number of abdominal wall or peritoneal recurrences | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Follow-up (months) | 66 | 12 | 14 | 8 | 18 | 30 | 48 | 20 |